Skip to content

Handled Echocardiography and Chronic Heart Failure

Management of Chronic Heart Failure: Role of the Handled Echocardiography in Home Monitoring Care Programs

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01365325
Enrollment
118
Registered
2011-06-03
Start date
2009-01-31
Completion date
2010-12-31
Last updated
2011-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Heart Failure

Brief summary

The aim of the study is to compare two different home monitoring care programs in patients with chronic heart failure in functional class NYHA III, one of them based on clinical and electrocardiographic evaluations, the other one using also periodical handled echocardiographic examinations.

Detailed description

Randomized, blinded, controlled, monocentric study comparing two different home monitoring care programs in patients with chronic heart failure in functional class NYHA III, one of them based on clinical and electrocardiographic evaluations every three months, the other one using also periodical handheld echocardiographic examinations at the 6th, 12th and 18th month. The events occurring during the 18 month follow up and the results of the final echocardiography performed in all the patients will be transmitted to and evaluated by an independent observer, unaware of the features of the follow up. At the end of the trial, the randomization code will be opened and the events will be ascribed to the two groups. The primary end point is rehospitalization for worsening of heart failure symptoms and/or for the appearance of major vascular events during the 18 months follow up. Secondary end points include home treated vascular events, cardiovascular death and the composite end point death + rehospitalization.

Interventions

OTHERhandled echocardiography in home monitoring program

home monitoring with clinical evaluations and ECG every three months and echocardiography examinations at the 6th, 12th and 18th month

OTHERecg and clinical evaluation in home monitoring program

home monitoring with clinical evaluations and ECG every three months

Sponsors

Federico II University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
70 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Chronic Heart Failure in functional class NYHA III * At least once hospitalization during the last year for worsening of clinical symptoms or for the appearance of acute cardiovascular events * Patients who cannot easily reach the pertaining Sanitary District for different reasons (i.e. the presence of architectural barriers, the absence of a lift, a too great distance between home and Sanitary District without someone helping) * age ≥ 70 years * written informed consent

Exclusion criteria

* Patients who were waiting for cardiac surgery or patients who had undergone a cardiac operation within three months

Design outcomes

Primary

MeasureTime frame
Rehospitalization for worsening of heart failure symptoms and/or for the appearance of major vascular events18 months

Secondary

MeasureTime frameDescription
Home treated major vascular events18 monthsNumber of Participants with major vascular events occurred during the 18 months follow up who did not go to the Hospital and were home treated
Cardiovascular death18 months
Composite end point death + rehospitalization18 months

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026